Probiotics for rectal volume variation during radiation therapy for prostate cancer

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):646-50. doi: 10.1016/j.ijrobp.2013.07.038. Epub 2013 Sep 18.

Abstract

Purpose: To investigate the effect of the probiotic Lactobacillus acidophilus on the percentage volume change of the rectum (PVCR), a crucial factor of prostate movement.

Methods and materials: Prostate cancer patients managed with tomotherapy as a radical treatment were enrolled in the study to take a probiotic capsule containing 1.0×10(8) colony-forming units of L acidophilus or a placebo capsule twice daily. Radiation therapy was performed at a dose of 78 Gy in 39 fractions. The PVCR, defined as the difference in rectal volume between the planning computed tomographic (CT) and daily megavoltage CT images, was analyzed.

Results: Forty patients were randomized into 2 groups. The L acidophilus group showed significantly lower median rectal volume and median PVCR values than the placebo group. L acidophilus showed a significant reduction effect on the PVCR (P<.001). However, the radiation therapy fraction number did not significantly influence the PVCR.

Conclusions: L acidophilus was useful in reducing the PVCR, which is the most important determining factor of prostate position, during radiation therapy for prostate cancer.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bacterial Load
  • Gases
  • Humans
  • Lactobacillus acidophilus*
  • Male
  • Middle Aged
  • Movement
  • Organ Size
  • Probiotics / therapeutic use*
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / radiotherapy*
  • Radiography
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted / methods
  • Rectum / anatomy & histology*
  • Rectum / diagnostic imaging
  • Rectum / physiology

Substances

  • Gases